WHO POINTS TO CONSIDER IN CONTINUOUS MANUFACTURING OF PHARMACEUTICAL PRODUCTS.
| Publicado en: | WHO Drug Information Vol. 39; no. 1; pp. 63 - 79 |
|---|---|
| Formato: | glossary tables/charts Journal Article |
| Publicado: |
World Health Organization
2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=184773988&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 184773988 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10109609 6FV jtl: WHO Drug Information issn: 10109609 maglogo: N pubinfo: dt: 2025 vid: 39 iid: 1 pid: 437 pub: World Health Organization artinfo: ui: 184773988 184773988 184773988 184773988 ppf: 63 ppct: 16 formats: fmt: @attributes: type: P tig: atl: WHO POINTS TO CONSIDER IN CONTINUOUS MANUFACTURING OF PHARMACEUTICAL PRODUCTS. aug: sug: subj: World Health Organization Pharmacy and Pharmacology Pharmaceutical Companies Technology, Medical Professional Competence Workforce Risk Management pubtype: Academic Journal doctype: glossary tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|